• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝移植的适应证及时机]

[Indications and timing of liver transplantation].

作者信息

Ruf Andrés E, Villamil Federico G

机构信息

Unidad de hepatología, cirugía hepatobiliar y trasplante hepático, Fundación Favaloro.

出版信息

Acta Gastroenterol Latinoam. 2008 Mar;38(1):75-88.

PMID:18533359
Abstract

Liver transplantation (OLT) is indicated in patients with severe and irreversible acute or chronic liver disease without alternative therapy and in the absence of contraindications. Indications for OLT can be grouped in four categories, namely cirrhosis, fulminant hepatitis, malignant hepatic tumors and liver-based genetic defects that trigger damage of other organs. Patients with cirrhosis should be referred for OLT after the onset of any of the major complications or coagulopathy. Early referral is crucial in fulminant hepatitis due to the high mortality with medical therapy and the unpredictable nature of this condition. Ideal timing for OLT is the moment in the natural history of the disease when the expected survival of patients on the waiting list is higher with than without OLT. Recent data suggest that maximal benefit of OLT is obtained in patients with a MELD score >15. However, in some cases with no imminent risk of death, OLT is indicated to improve quality of life or to prevent contraindications such as progression of hepatocellular carcinoma. At present, there is a marked disproportion between the number of donors available and the growing number of patients listed worldwide, which in turn has resulted in prolongation of the time-interval to OLT and waitlist mortality. The rationale of allocation systems utilizing the MELD score is to prioritize on the waiting list patients with severe liver dysfunction ("the sickest first") and those with hepatocellular carcinoma who may loose the benefits of OLT when waitlist time exceeds eight months.

摘要

肝移植(OLT)适用于患有严重且不可逆的急性或慢性肝病、无替代治疗方法且无禁忌症的患者。OLT的适应症可分为四类,即肝硬化、暴发性肝炎、肝脏恶性肿瘤以及引发其他器官损害的肝脏基因缺陷。肝硬化患者在出现任何主要并发症或凝血障碍后应转诊进行OLT。对于暴发性肝炎,早期转诊至关重要,因为药物治疗死亡率高且病情不可预测。OLT的理想时机是在疾病自然史中,等待名单上的患者接受OLT比不接受OLT预期生存率更高的时刻。近期数据表明,终末期肝病模型(MELD)评分>15的患者接受OLT获益最大。然而,在一些没有即刻死亡风险的情况下,进行OLT是为了改善生活质量或预防诸如肝细胞癌进展等禁忌症。目前,全球可用供体数量与登记患者数量的增长之间存在明显失衡,这反过来导致了OLT时间间隔延长和等待名单上的患者死亡率上升。利用MELD评分的分配系统的基本原理是在等待名单上优先考虑肝功能严重受损的患者(“病情最重者优先”)以及那些等待名单时间超过八个月可能会失去OLT益处的肝细胞癌患者。

相似文献

1
[Indications and timing of liver transplantation].[肝移植的适应证及时机]
Acta Gastroenterol Latinoam. 2008 Mar;38(1):75-88.
2
Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.肝移植等待名单中终末期肝病模型(MELD)评分分析
Transplant Proc. 2007 Oct;39(8):2511-3. doi: 10.1016/j.transproceed.2007.07.023.
3
Algorithm for prioritization of patients on the waiting list for liver transplantation.肝移植等待名单上患者优先级排序算法
Transplant Proc. 2007 Jul-Aug;39(6):1855-6. doi: 10.1016/j.transproceed.2007.05.059.
4
Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?用于评估等待肝移植患者的终末期肝病模型(MELD)评分系统:比Child-Turcotte-Pugh(CTP)系统更好吗?
Transplant Proc. 2008 Jul-Aug;40(6):1906-9. doi: 10.1016/j.transproceed.2008.05.072.
5
RIFLE criteria and hepatic function in the assessment of acute renal failure in liver transplantation.RIFLE标准与肝功能在肝移植急性肾衰竭评估中的应用
Transplant Proc. 2010 May;42(4):1233-6. doi: 10.1016/j.transproceed.2010.03.128.
6
[Orthotopic liver transplantation (first clinical experience)].[原位肝移植(首次临床经验)]
Khirurgiia (Mosk). 1993 Mar(3):32-44.
7
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.终末期肝病评分模型是人类免疫缺陷病毒1感染的终末期肝病患者最佳的预后因素:一项前瞻性队列研究。
Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.
8
Exclusions and deaths on the liver transplant waiting list.肝移植等待名单上的排除情况和死亡病例。
Transplant Proc. 2010 Mar;42(2):622-4. doi: 10.1016/j.transproceed.2010.02.009.
9
Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.在一个单一中心进行的198例肝移植手术中,终末期肝病模型(MELD)评分与尸体供体的器官分配情况。
Transplant Proc. 2008 Jul-Aug;40(6):1903-5. doi: 10.1016/j.transproceed.2008.05.016.
10
Analysis of liver transplantation outcome in patients with MELD Score > or = 30.对终末期肝病模型(MELD)评分≥30分患者的肝移植结局分析。
Transplant Proc. 2008 Apr;40(3):797-9. doi: 10.1016/j.transproceed.2008.03.016.